Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)

Completed · Phase 3 · Has a placebo group

Conditions studied: Chronic Obstructive Pulmonary Disease (COPD)

In brief

The purpose of this study is to measure the effectiveness and safety of TD 4208, an investigational drug being developed to treat people with moderate to very severe COPD, compared to placebo, a treatment without activity.

Key facts

Study ID

NCT02459080

Run by

Mylan Inc.

People needed

619

Starts

2015-09-01

Expected to finish

2016-09-01

Last updated by the study team

2022-02-24

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject is a male or female subject 40 years of age or older

You may not qualify if…

• Females who are pregnant, lactating, breast-feeding or planning to become pregnant during the study

Where it is running

• Allergy Associates Research Center (AARC) — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.